Cim Investment Management Inc Tg Therapeutics, Inc. Transaction History

Cim Investment Management Inc

  • $332 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 16, 2023
BUY
$10.23 - $19.34 $5,473 - $10,346
535 Added 3.57%
15,521 $233,000
Q1 2022

May 17, 2022
BUY
$7.81 - $20.45 $68,509 - $179,387
8,772 Added 141.17%
14,986 $143,000
Q2 2021

Aug 13, 2021
BUY
$32.5 - $48.96 $201,955 - $304,237
6,214 New
6,214 $241,000

Others Institutions Holding TGTX

# of Institutions
336
Shares Held
87.6M
Call Options Held
2.35M
Put Options Held
1.7M
View Full List

About TG THERAPEUTICS, INC.

TGTX Quotes by TradingView
  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.23B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Cim Investment Management Inc Portfolio

Follow Cim Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cim Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cim Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email